Serina Therapeutics Inc (SER): Price to Sales

Corporate company logo of Serina Therapeutics Inc (SER)

Serina Therapeutics, Inc. (SER) automates polymer synthesis via AI-driven robotics, attracting top chemists with unique patents that guarantee high scientific potential. However, a reliance on grants due to the absence of commercial products creates risks. The P/S ratio history clearly confirms this volatility, where the parameter value equals 311.20, allowing for a real-time assessment of the business's market value relative to its actual sales.

Serina (SER) Market Cap to Revenue: for the period 03/28/2024 - 11/17/2026

Analytical breakdowns for Serina Therapeutics Inc (SER)

- current price and projected stock value:
- stock exchange capitalization data:
Fundamental company analysis:Serina Therapeutics, SER
Core merchandise of Serina Therapeutics

To build a high-quality portfolio, I use P/S as a leading indicator of market expectations. This metric correlates the current market value of a business with its annual revenue, measuring investors' willingness to pay a premium per unit of sales. For Serina Therapeutics, Inc. (SER), this ratio reflects the market's confidence in the commercial success of the POZ platform and the safety of its Parkinson's disease therapy. By analyzing the market cap-to-revenue ratio, one can assess the risk of a price correction should the efficiency of clinical trials decline.